Metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient
- 30 April 2008
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 31 (4), 375-379
- https://doi.org/10.1016/j.ijantimicag.2007.12.006
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfacesJournal of Hospital Infection, 2005
- Molecular Characterization of a β-Lactamase Gene, bla GIM-1 , Encoding a New Subclass of Metallo-β-LactamaseAntimicrobial Agents and Chemotherapy, 2004
- Dissemination in distinct Brazilian regions of an epidemiccarbapenem-resistant Pseudomonas aeruginosa producing SPM metallo- -lactamaseJournal of Antimicrobial Chemotherapy, 2003
- Imipenem-EDTA Disk Method for Differentiation of Metallo-β-Lactamase-Producing Clinical Isolates of Pseudomonas spp. and Acinetobacter sppJournal of Clinical Microbiology, 2002
- Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relativesThorax, 2002
- Metallo-β-Lactamase VIM-2 in Clinical Isolates ofPseudomonas aeruginosafrom PortugalMicrobial Drug Resistance, 2002
- Characterization of Class 1 Integrons from Pseudomonas aeruginosa That Contain the bla VIM-2 Carbapenem-Hydrolyzing β-Lactamase Gene and of Two Novel Aminoglycoside Resistance Gene CassettesAntimicrobial Agents and Chemotherapy, 2001
- PCR mapping of integrons reveals several novel combinations of resistance genesAntimicrobial Agents and Chemotherapy, 1995
- Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosisJournal of Hospital Infection, 1987